This article introduces the basic principles of magnetic resonance (MR) perfusion imaging of liver and summarized the currently available literature. Perfusion magnetic resonance imaging (MRI) is a functional imaging technique that quantifies the microcirculatory status of liver parenchyma and liver lesions such as flow, permeability, fractional intravascular volume and fractional interstitial volume. It potentially allows one to (i) detect liver metastases, (ii) assess effectiveness of anti-angiogenic therapy, (iii) assess viable tumour after therapy or ablation, and (iv) diagnose cirrhosis and assess its severity. Further work is required to establish and validate perfusion MRI as a clinical modality.
IntRoductIon
Perfusion magnetic resonance imaging (MRI) refers to the use of MRI to assess blood flow at the tissue level, i.e. tissue microcirculation. Blood flow in the macroscopic vessels such as the portal vein and hepatic arteries can be directly measured by Doppler ultrasound (US), contrast-enhanced US, Xenon computed tomography (CT) or Phased Contrast magnetic resonance (MR) angiography. However, perfusion imaging focuses on microscopic vessels and these techniques will not be included in this paper. This paper will focus on Dynamic Contrast-Enhanced MRI (DCE MRI) techniques with tracer kinetic modelling that allow characterisation of microcirculatory state in tissue. Some DCE liver perfusion studies using modalities other than MRI may be discussed to illustrate the value of perfusion imaging.
noRMAL And AbnoRMAL LIveR cIRcuLAtIon
The liver is a highly vascular organ consisting of a series of porous vascular channels (sinusoids with fenestrae) that are predominantly supplied by the portal vein (75%) and supplemented by the hepatic artery (25%) 1 . The two arterial inputs mix in the sinusoids at different time intervals to supply the liver cords. There is small space (Space of Disse) separating the sinusoids from tight cords consisting of two rows of closely apposed hepatocytes. The Space of Disse may be considered as an interstitial space. However, due to the large size of the fenestrae of the sinusoids, there is free exchange of low molecular weight compounds (such as Gadolinium contrast agents) between the vascular space (sinusoids) and the interstitial space (Space of Disse) (Figs. 1 and 2) 2 .
In cirrhosis, due to sinusoidal capillarisation, there is loss of normal fenestrae, new deposition of basement membrane and new formation of capillary tight junctions. There is also deposition of fibres by activated Ito cells, enlarging the Space of Disse. As a result, the transfer of gadolinium contrast agents is more hindered (Fig. 2) 3 .
In liver metastases and HCC, tumour blood supply initially comes from proliferation of the sinusoidal introduction to Liver perfusion MRi Proceedings of Singapore Healthcare  Volume 19  Number 1  2010 Fig. 1 . Schematic diagram illustrating the dual blood supply of the liver supplying sinusoids. Note that the Space of Disse is an interstitial space between the liver cords and the sinusoids. (B) . Note that in cirrhosis (B) there is an increase in the number of stellate cells, increase in deposition of fibres in the Space of Disse, and loss of fenestrae as the sinusoids become more capillary-like.
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Proceedings of Singapore Healthcare  Volume 19  Number 1  2010 cells that become capillarised with loss of fenestrae and new formation of basement membrane. This results in a significant barrier to low molecular weight compounds and hence creates a significant interstitial space. There is also subsequent recruitment of neovessels directly supplied by the hepatic artery (neoarteriogenesis). This is a prominent feature of HCC but is also seen in the peritumoural area of liver metastases [4] [5] [6] [7] .
tRAceR kInetIc ModeLLIng (ModeL-bAsed APPRoAch)
This technique assumes that the imaged voxel consists of a microscopic artery supplying a permeable capillary that leaks tracer (gadolinium contrast) into the interstitium ( Fig. 3 ) and draining away via a microscopic venule. The vessel and the interstitium are beyond the resolution of the scanner to directly image. What is measured by the scanner is the average concentration of the tracer within the voxel. The principle of tracer kinetic modelling is to mathematically model the tissue concentration-time curve based on variables such as hepatic arterial (HA) flow, portal venous (PV) flow, fraction of total flow contributed by hepatic artery, capillary permeability-surface area product (PS), percentage of intravascular space (v1), percentage of interstitial space (v2), and mean transit time (MTT). Using the technique of curve fitting, the arterial input concentration-time curves (hepatic artery and portal vein) are fitted with different values of the above variables to yield the best fit for the tissue concentration-time curves.
dynAMIc MuLtIPhAsIc ct And MR fIndIngs exPLAIned by tRAceR kInetIc ModeLLIng
It is observed that a hypervascular tumour (a tumour with large vascular space relative to the interstitial space) shows a pattern of rapid arterial enhancement followed by washout whereas a hypovascular tumour (a tumour with larger interstitial space relative to the vascular space) shows progressive enhancement. These phenomenon can be explained by tracer kinetic modelling.
The hypervascular tumour is predominantly supplied directly by hepatic arterial neovessels. As the intravascular space is much larger than the interstitial space, the average concentration imaged by the voxel predominantly reflects changes in the intravascular space. Hence there is rapid and strong enhancement in the arterial phase. However, in the equilibrium phase, the contrast re-distributes to the interstitium of the rest of the body. This reduces the concentration of tracer in the vascular space and is imaged as "wash-out" by the voxel.
The hypovascular tumour is supplied by both the hepatic artery and the portal vein. As the interstitial space is much larger than the intravascular space, the average concentration imaged by the voxel predominantly reflects changes in the interstitial space. Hence there is faint enhancement in the arterial phase as the contrast diffuses into the relatively large interstitial space. As there is continued blood supply in the portal venous phase, more tracer diffuses into the interstituim during the portal venous phase and the tracer concentration in the interstitium increases. In the equilibrium phase, although the tracer concentration in the vascular space has reduced due to redistribution to the rest of the body, it is still higher than the concentration in the tumour interstitium. Hence, there is continued net efflux of contrast into the interstitium in the equilibrium phase and the net result is the voxel demonstrating a pattern of progressive enhancement.
Model-based MR liver perfusion technique may allow quantification of these microvascular parameters. This may contribute to better understanding and better differential diagnoses of focal liver lesions.
Model-based Approach
There are several models used for liver perfusion (Fig. 4 ). They differ from each other in the following:
1. Single-input or dual-input: Is the liver input estimated solely from the hepatic artery only or from both the hepatic artery and the portal vein?
Dual-input models reflect known pathophysiology better.
Single-compartment or dual-compartment: Is
the liver tissue modelled as a single compartment (vascular space only) or is there also an interstitial space (second compartment)?
Single-compartment models are computationally simpler and are accurate for the normal liver as the Space of Disse communicates 
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Conventional compartment model (CC) or
distributed parameter (DP) model: does the liver tissue model assume instantaneous mixing of the contrast within the vascular space (CC model) or does the model take into account a concentration gradient within the vascular space (DP model)?
CC models are computationally easier to solve. DP models are computationally more intensive and require higher temporal resolution data.
4. Derived microcirculatory parametersparameters related to an interstitial space (such as interstitial volume, permeability and extraction fraction) are only derived in a dual-compartment model and not a singlecompartment model.
Model-free Approach
There are several model-free approaches to assessing liver perfusion. They are based on the fact that the perfused liver show enhancement with arrival of contrast agent and therefore perfusion can be estimated by the rate of tissue enhancement . Hence most model-free approaches use parameters derived from the initial slope of the tissue concentration-time curve.
Hepatic Perfusion Index
Hepatic perfusion index (HPI) was initially proposed by Miles et al 8 . HPI refers to the proportion of hepatic perfusion that is derived from the hepatic artery, and it can calculated by the following formula:
Arterial perfusion /Arterial perfusion + Portal venous perfusion.
Miles et al 8 used the time to peak in the splenic enhancement curve to distinguish between the arterial and portal venous phases of the liver. Liver arterial perfusion was then estimated by the maximum slope in the liver enhancement curve before the splenic peak (g a ), divided by the peak aortic enhancement (Fig. 5 ). Correspondingly, liver portal venous perfusion was estimated by dividing the maximum slope in the liver enhancement curve after the splenic peak (g p ) by the the peak aortic enhancement. 
Portal Venous Perfusion Index
A portal venous perfusion index (PPI) was subsequently introduced by Blomley et al 9 .
PPI refers to the ratio of portal venous to total liver perfusion, i.e. PPI = 1 -HPI. Contributions from the hepatic artery are removed from the liver concentration-time curve by subtracting from it a scaled splenic concentrationtime curve. This is because the spleen is predominantly supplied by the aorta and is not supplied by the portal vein. Using the arterially subtracted liver concentration-time curve, the portal venous perfusion was estimated by dividing the maximum slope of the arterially subtracted liver curve by the peak aortic enhancement. Liver arterial perfusion was estimated in a similar way as Miles et al 8 .The advantage of using such model-free indices is that they are easy to derive and do not require much computation.
scan technique
The ideal requirement for MR liver perfusion scanning is to acquire, in rapid temporal resolution (about 4 seconds or less), in a scan plane containing the lesion, the aorta and the portal vein so that tracer concentration can be calculated and concentration-time curves derived.
Gadolinium is the tracer used. Gadolinium concentration may be calculated from its T1 shortening properties or its T2* shortening properties. Techniques exploiting the T1 shortening properties are more useful as modelling the extravasation of gadolinium into the interstitium allows calculation of capillary permeability-surface area product (PS) and fractional interstitial space (v2). A T1-weighted 3D spoiled gradient echo technique with variable flip angles is a useful sequence. Sensitivity encoding may be used to reduce scan time. The 3D sequence eliminates inaccuracies due to the RF excitation pulse profile found in 2D sequences. The peripheral slices (usually 2) should be excluded from analysis as they are usually degraded by wrap artifact. A T1 map can be calculated by using the variable flip angle method described by Wang et al 10 . Gadolinium concentration is inversely proportional to change of the reciprocal of T1. Hence a gadolinium concentration-time curve can be derived the T1 maps before and after gadolinium. Although some workers have advocated the simpler approach of estimating gadolinium concentration by the difference in MR image signal intensities before and after tracer arrival, the authors would like to caution that the success of this simplified approach might be dependent on the imaging sequence, as well as the range of signal intensity and tracer concentration.
cLInIcAL APPLIcAtIons Liver Metastases

Model-Free Approach
Several studies have shown the potential of perfusion studies to detect changes in the liver of patients at risk of liver metastases. Totman et al showed that there was a difference in PPI between patients with and without cancer 11 . Leggett et al showed that there is a difference in HPI between patients with overt metastases and patients without 12 . Tsushima et al showed that the normal looking liver in a patient with liver metastases show changes in PPI suggesting that there is potential of using liver perfusion studies to detect microscopic metastases 13 . This potential is corroborated by several nuclear medicine studies by Warren et al and Ballantyne et al 14, 15 . However follow-up data is only available in 8 patients in Leggett et al's study, of which 3 patients who subsequently developed liver metastases all showed decreased portal perfusion 12 . Although there is potential to use liver perfusion studies to detect or predict microscopic liver metastases, more work involving longitudinal studies is required to establish a role for liver perfusion.
Meijerink et al showed the potential of using functional liver perfusion maps to supplement routine radiological diagnosis of liver metastases 16 . Compared to routine 4-phase CT, total-livervolume CT perfusion studies using HPI increased sensitivity to 89.2 from 78.4% and specificity to 82.6 from 78.3%. Four out of a total of 37 lesions were detected with the help of perfusion maps. There are abnormal perfusion changes noted at the rim of the liver lesions that make them look bigger and hence facilitate detection of small lesions. However, total-liver-volume CT incurs radiation burden. There is potential to use MR liver perfusion to improve diagnosis of liver metastases.
Model-based Approach
There are fewer studies using the modelbased approach.
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Cuenod et al used a dual-input single-compartment model in rats and found that micrometastases in an apparently normal liver caused a 34% decrease in portal blood flow and a 25% increase in the mean transit time for blood to pass through the liver 17 . The changes are similar for macrometastases but more marked.
Koh et al used a dual-input dual-compartment DP model in 3 patients in a technical study 18 . Compared to single-compartment models, the dual-compartment model allows assessment of the presence and size of the second compartment (fractional interstitial space) and extravasation characteristics from the vascular compartment to the interstitial compartment such as capillary permeability-surface area product (PS) and extraction ratio. The group found that normal liver had zero or near zero interstitial space and PS (explained by the fact that large fenestrae allow free exchange between the Space of Disse and the sinusoids) and that liver metastases has a non-zero and finite interstitial space and PS. There was an increase of arterial fraction (arterial flow/sum of arterial and portal flow) to the metastases but portal flow remains significant. The findings are consistent with the histopathological observations of Liu and Matsui 4 .
The dual-input dual-compartment DP model shows potential to characterise microcirculatory pathophysiology but larger studies are required to confirm the findings.
hepatocellular carcinoma Model-Free Approach
Abdullah et al studied the difference between colorectal metastases and hepatocellular carcinoma (HCC) and found no significant difference in HPI 19 . However there was an increase in arterial flow, portal flow, and total blood flow in HCC compared to colorectal metastases. The distribution volume is also higher in HCC.
Model-Based Approach
Fournier et al used the dual-input singlecompartment on rats and found that HCC had high arterial flow and low portal flow 20 .
Sahani et al used a single-input dual-compartment DP model on HCC and found that blood flow, blood volume and PS was higher in well differentiated HCC compared to moderately and poorly differentiated HCC.
Koh et al used the dual-input dual-compartment DP model on 4 patients with HCC and found that the fractional interstitial space and the associated extravasation parameters (PS and extraction ratio), like liver metastaes, is non-zero 21 . HCC was shown to have increased arterial flow, increased total blood flow as well as early contrast arrival time. The early contrast arrival was postulated to be related to arteriogenesis and direct supply of the tumour by branches of the hepatic artery. Tumour vascularity (fractional intravascular volume) was higher for 2 out of 4 patients. Portal venous flow is decreased but remains significant. The derived microcirculatory parameters are concordant with known histopathology 7, 22 .
Together with other modalities such as Diffusionweighted MRI, MR perfusion has the potential to contribute to multi-parametric functional assessment of the liver to improve diagnosis 23 .
Assessment of Response
Anti-angiogenic therapy has recently emerged as a new class of agents targeting tumour vasculature. Anti-angiogenic therapy is based on the observation that tumour require neovessels for survival. Based on the diffusion distances of oxygen and nutrients, tumour cells cannot survive if they are further than 2mm from a neovessel. Hence effective anti-angiogenic therapy has the potential to control the primary tumour as well as its metastasis. However, current methods of assessing efficacy of chemotherapy, such as RECIST, are based on the decrease in size of tumour. Effective anti-angiogenic therapy predominantly manifests as lack of tumour growth rather than decrease in tumour size as the therapy is not cytotoxic. Hence there is a need for a functional imaging modality to assess the efficacy of such therapy. The same principle holds true for HCC that undergo local ablation. Ablated tumour differs from viable tumour in blood supply. Consensus conferences have recommended that the RECIST criteria be modified in HCC to assess only the viable tumour [24] [25] [26] . Viable tumour is defined as tumour that shows enhancement in the arterial phase. MR perfusion has the potential to provide more functional information that can be used in response assessment and assessment of viable tumour and necrosis 27 
Model-Free Approach
Wang et al used modified parameters to analyse the arterial uptake slope in MR liver perfusion studies in patients with HCC treated with Thalidomide 28 . It was found that there was a greater decrease in peak enhancement, maximum enhancement and enhancement slope percentage in patients without disease progression compared to patients with progression.
Miyazaki et al used HPI for assessment of efficacy of antiangiogenic therapy and found a median decrease of 15% in HPI observed at 28 days after antiangiogenic treatment 29 .
Meijerink et al used HPI and found a decrease in perfusion with anti-angiogenic therapy using AZD2171 and gefitinib 30 .
More studies are required to establish if MR liver perfusion can serve as a biomarker for antiangiogenic drug therapy.
Meijerink et al studied the use of HPI in assessing local recurrence in liver metastases undergoing RFA and found that changes in HPI paralleled PET in 13 recurrences 31 .
Model-Based Approach
Chen et al studied effects of trans-arterial chemoembolisation with a dual-input dual-compartment DP model and found that hepatic arterial fraction, hepatic arterial perfusion and hepatic blood volume reduced with effective embolisation and can be used to detect viable tumour 32 .
cirrhosis
Model-Free Approach
Increase in hepatic arterial perfusion and decrease in portal venous perfusion are observed in perfusion scintigraphy studies 33 .
Miles et al and Blomley et al found an increase in HPI and PPI, respectively, in cirrhotic liver 8, 9 .
Model-Based Approach
Guan et al used a dual-input dual-compartment DP model on rats and found that as diethylnitrosamine induced a continuum of hepatitis, hepatic fibrosis and eventually cirrhosis, that there was a gradual increase of hepatic arterial flow and mean transit time. There was a corresponding gradual decrease of blood volume and blood flow 34 .
Koh et al used a dual-input dual-compartment DP model and found that cirrhotic livers show a nonzero fractional interstitial space whereas normal liver showed a near-zero interstitial space 21 .
Hashimoto et al used a dual-input dualcompartment DP model and found that the hepatic arterial fraction increases with extent of fibrosis and cirrhosis 35 .
Annet et al used a dual-input single-compartment CC model and found that microcirculatory parameters correlated with severity of cirrhosis and portal pressure 36 . Measured portal pressure correlated with portal fraction, portal perfusion and mean transit time. Severity of cirrhosis as assessed by Child-Pugh class correlated with portal fraction, portal perfusion, arterial perfusion and mean transit time. Cirrhotic livers show an increase in arterial perfusion, decrease in portal perfusion, decrease in total blood flow, and increase in mean transit time.
Van Beers et al obtained similar results in an earlier study and found that a cut-off of 22.6 sec of mean transit time enabled diagnosis of cirrhosis with sensitivity and specificity of 81% 37 .
Hagiwara et al used a dual-input singlecompartment CC model and found that there was increase in arterial blood flow, arterial fraction, distribution volume, and mean transit time in patients with advanced hepatic fibrosis 38 . Receiver operating curve analysis showed that mean transit time, distribution volume and arterial flow are good predictive parameters with area under the receiver operating characteristic curve ranging from 0.791-0.824; sensitivity, 76.9-84.6%; and specificity, 71.4-78.5%.
MR liver perfusion has potential for non-invasive diagnosis of cirrhosis and assessment of the severity of the condition.
concLusIon
MR liver perfusion provides functional information about the microcirculation of liver parenchyma and liver lesions and is potentially useful for: (1) improving detection of liver metastases;
(2) assess the efficacy of anti-angiogenic therapy; (3) assessing viable HCC after therapy or ablation; (4) diagnosing cirrhosis and assessing its severity.
